findmyKOL

George Washko, MD

Enriched profile

Associate Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital

ORCIDNPI
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyPulmonary DiseaseFocusChronic Obstructive Pulmonary Disease (COPD) Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding2007–2026

George Washko is Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. OpenAlex indexes 618 publications with 31,231 citations (h-index 88); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

George R. Washko, MD, is Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital / Harvard Medical School. The public record shows 618 publications with 31,231 citations (h-index 88), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension Research and Treatments. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies, 8 NIH-funded awards (2007–2026).

  • Most recent indexed publication: 2024 · American journal of respiratory and critical care medicine
  • Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Diseases2 trialsLung Cancer (NSCLC/SCLC)Pulmonary HypertensionCOPDIdiopathic Pulmonary Fibrosis

Research focus

OpenAlex concept fingerprint
Chronic Obstructive Pulmonary Disease (COPD) ResearchInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and TreatmentsLung Cancer Diagnosis and TreatmentRespiratory Support and Mechanisms

Drugs & molecules

across trials, industry payments and publications
Breztrigeneric · Budesonide / formoterol / glycopyrroniumClinical trialsIndustry payments10PublicationsFasenrageneric · BenralizumabClinical trialsIndustry payments3PublicationsOpsumitgeneric · MacitentanClinical trialsIndustry payments3Publications

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trialsIndustry payments25AstraZeneca UK LimitedClinical trialsIndustry payments15Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trialsIndustry payments4

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
618publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

31,231citations

Total citations across indexed works.

88h-index

Hirsch index (OpenAlex). i10-index 329.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
8NIH grants · 2007–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 27 Aug 2026

8 NIH research awards on record, funded 20072026 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

1 congress contribution (2022) across AACR per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Raúl San Jośe Estépar299Edwin K. Silverman155Alejandro A. Díaz116

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/scientific-contributions/George-R-Washko-39415004

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    copd-drug-development.com/speaker/george-washko

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →copd-drug-development.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Co-Director

    Applied Chest Imaging Laboratory (ACIL), Brigham and Women's Hospital

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acil.bwh.harvard.edu
  • Regional/National Principal Investigator

    NHLBI COPD Clinical Research Network (1 of 10 national PIs)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lmi.bwh.harvard.edu

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Faculty member

    Laboratory of Mathematics in Imaging (LMI), Brigham and Women's Hospital / Harvard

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lmi.bwh.harvard.edu
  • Associate Physician

    Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lmi.bwh.harvard.edu

Media & interviews

press, podcasts and appearances
  • Guest

    Lungcast podcast (American College of Chest Physicians / respiratory health series), discussed the Lung Health Cohort Research Study alongside Ravi Kalhan MD and Amy Olson MD

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com
  • Speaker/panelist

    COPD Drug Development Summit, panel "Thinking Beyond Exacerbations & Lung Function to Define the Future of Clinical Endpoints"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →copd-drug-development.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.